Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
phase 3
Pharma
ImmunityBio shares tank despite ph. 3 win in first-line NMIBC
With a phase 3 win in front-line non-muscle invasive bladder cancer, ImmunityBio is heading to the FDA for a label expansion.
Donavyn Coffey
Nov 10, 2026 3:06pm
Rhapsido ph. 3 in MS combines superior safety with strong efficacy
Oct 26, 2026 11:05am
Argenx reports Q3 sales bump and a new trial requirement
Oct 23, 2026 11:42am
Veradermics ph. 3 win backs up its stellar stock performance
Oct 20, 2026 10:10am
EyePoint reeling for stability after another AMD ph. 3 flop
Oct 19, 2026 11:32am
Mirum keeps momentum with ph. 3 win for Livmarli
Oct 12, 2026 11:18am